|
|
|
|
 |
Two international leaders in cancer research and drug development have announced completion of master agreements that will more effectively accelerate translational research and ultimately, bring new cancer drugs to patients faster.
|
|
|
 |
The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
|
|
|
|
|
